|
|
Home » Books » Science » Medicine » Oncology
Anti-cancer Drug Development
http://www.fishpond.co.nz/Books/Anti-cancer-Drug-Development-Bruce-C-Baguley-Edited-by-David-J-Kerr-Edited-by/9780120726516
By
Bruce C. Baguley (Edited by), David J. Kerr (Edited by)
This item is unavailable.We will email you if this item comes back into stock. | Rating: | | | Format: | Hardback, 397 pages | | Other Information: | Illustrations (some col.) | | Published In: | United Kingdom, 17 November 2001 |
Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. It is one work that can be consulted for all aspects of anticancer drug development. Key features include: concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts; a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death; detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products; discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques; hundreds of references that allow the reader to access relevant scientific and medical literature; and, clear illustrations, some in color, that provide both understanding of the field and material for teaching. |
About the AuthorEdited by Bruce C. Baguley and David J. Kerr PrizesKEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching Reviews"..this is a really extensive and comprehensive book on the drug development process. ...There is very little overlap between chapters and all are written by experts in the field. Hundreds of useful references are included for those wanting to go further. ...Very good value...and essential reading for both the scientist and Ph.D. student. Definately one for the library to stock." -Paul Loadman, University of Bradford, UK for BRITISH JOURNAL OF CANCER (2002) "Well-referenced and indexed...this text would be a useful addition to the clinic, research laboratory and institution library." --P. Parsons, Queensland Institute of Medical Research for CANCER FORUM (2002)
| Publisher: | Academic Press Inc | | ISBN: | 0120726513 |
| EAN: | 9780120726516 | | Dimensions: | 28.75 x 21.69 x 2.13 centimeters (1.19 kg) |
| Age Range: |
15+ years |
|
Help
My Cart
New Zealand dollars.
